CIK 0001721484 · <br>Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472174146
- Phone
- 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Jhaveri Nirav S. Chief Financial Officer | Shares withheld for taxes | −742 | $2.59 | $2K | 29,258 |
| 2026-10-01 | Willard Stephen H Chief Executive Officer | Shares withheld for taxes | −1,987 | $2.59 | $5K | 74,916 |
| 2026-10-01 | Agafonova Nataliya Chief Medical Officer | Shares withheld for taxes | −2,913 | $2.59 | $8K | 68,778 |
| 2026-10-01 | Lehr Paul T General Counsel, Secretary | Shares withheld for taxes | −2,253 | $2.59 | $6K | 83,889 |
| 2026-10-01 | Blass Devin CTO & SVP of CMC | Shares withheld for taxes | −2,520 | $2.59 | $7K | 68,653 |
| 2026-08-19 | Lehr Paul T General Counsel, Secretary | Grant or award | +286,000 | 861,423 | ||
| 2026-08-19 | Hajjar Roger Joseph Director | Grant or award | +36,000 | 69,000 | ||
| 2026-08-19 | Soffer Rock Director | Grant or award | +36,000 | 262,034 | ||
| 2026-08-19 | Paletta George A. Jr. Director | Grant or award | +36,000 | 70,000 | ||
| 2026-08-19 | Ungaro Ursula Director | Grant or award | +36,000 | 77,000 | ||
| 2026-08-19 | Desai Arjun JJ Director | Grant or award | +36,000 | 36,000 | ||
| 2026-08-19 | Ascheim Deborah Director | Grant or award | +36,000 | 36,000 | ||
| 2026-08-19 | Cann Leah Rush Director | Grant or award | +36,000 | 36,000 | ||
| 2026-08-19 | Blass Devin CTO & SVP of CMC | Grant or award | +286,000 | 711,735 | ||
| 2026-08-19 | Agafonova Nataliya Chief Medical Officer | Grant or award | +286,000 | 716,914 | ||
| 2026-08-19 | Hare Joshua Chief Scientific Officer | Grant or award | +286,000 | 1,607,796 | ||
| 2026-08-17 | Jhaveri Nirav S. Chief Financial Officer | Grant or award | +300,000 | 300,000 | ||
| 2026-07-06 | Hare Joshua Chief Scientific Officer | Grant or award | +600,000 | 1,321,796 | ||
| 2026-07-06 | Hare Joshua Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2026-07-01 | Willard Stephen H Chief Executive Officer | Shares withheld for taxes | −18,046 | $0.73 | $13K | 771,681 |
Page 1 of 7 · 123 trades